JP2021522864A5 - - Google Patents
Info
- Publication number
- JP2021522864A5 JP2021522864A5 JP2021513373A JP2021513373A JP2021522864A5 JP 2021522864 A5 JP2021522864 A5 JP 2021522864A5 JP 2021513373 A JP2021513373 A JP 2021513373A JP 2021513373 A JP2021513373 A JP 2021513373A JP 2021522864 A5 JP2021522864 A5 JP 2021522864A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen epitope
- epitope repeat
- loop
- antigen
- bionanoparticles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024066590A JP2024105291A (ja) | 2018-05-10 | 2024-04-17 | Ｂ型肝炎感染症を処置するための方法および組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862669663P | 2018-05-10 | 2018-05-10 | |
| US62/669,663 | 2018-05-10 | ||
| PCT/US2019/031483 WO2019217654A1 (en) | 2018-05-10 | 2019-05-09 | Methods and compositions for the treatment of hepatitis b infection |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024066590A Division JP2024105291A (ja) | 2018-05-10 | 2024-04-17 | Ｂ型肝炎感染症を処置するための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021522864A JP2021522864A (ja) | 2021-09-02 |
| JP2021522864A5 true JP2021522864A5 (https=) | 2022-05-10 |
Family
ID=68466904
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021513373A Pending JP2021522864A (ja) | 2018-05-10 | 2019-05-09 | Ｂ型肝炎感染症を処置するための方法および組成物 |
| JP2024066590A Pending JP2024105291A (ja) | 2018-05-10 | 2024-04-17 | Ｂ型肝炎感染症を処置するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024066590A Pending JP2024105291A (ja) | 2018-05-10 | 2024-04-17 | Ｂ型肝炎感染症を処置するための方法および組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US11773141B2 (https=) |
| EP (2) | EP3810625B1 (https=) |
| JP (2) | JP2021522864A (https=) |
| KR (2) | KR20250027279A (https=) |
| CN (3) | CN120571006A (https=) |
| AU (2) | AU2019267680C1 (https=) |
| CA (1) | CA3099726A1 (https=) |
| ES (1) | ES2985391T3 (https=) |
| PL (1) | PL3810625T3 (https=) |
| WO (1) | WO2019217654A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025244940A1 (en) * | 2024-05-21 | 2025-11-27 | Clearb Therapeutics Ltd. | Methods and compositions for mrna- and dna-based treatment of hepatitis b infection |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4599231A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| US6740323B1 (en) * | 1999-11-24 | 2004-05-25 | Chiron Corporation | HBV/HCV virus-like particle |
| AUPQ912000A0 (en) | 2000-07-31 | 2000-08-24 | Crown In The Right Of The Queensland Department Of Health, The | Improved virus like particles |
| CN100381463C (zh) * | 2002-09-18 | 2008-04-16 | 中国人民解放军免疫学研究所 | 用于生产治疗用乙型肝炎疫苗或药物的免疫原及其制备方法和用途 |
| EP2292642A1 (en) | 2003-06-10 | 2011-03-09 | Opal Therapeutics Pty Ltd | Immunomodulating compositions, uses therefor and processes for their production |
| AU2015259470A1 (en) * | 2014-05-16 | 2016-11-10 | Yale University | Virus like vesicles (VLVs) based vaccines to prevent or treat chronic hepatitis B virus (HBV) infection |
| WO2017059878A1 (en) * | 2015-10-07 | 2017-04-13 | Humabs Biomed Sa | Antibodies that potently neutralize hepatitis b virus and uses thereof |
-
2019
- 2019-05-09 EP EP19799463.5A patent/EP3810625B1/en active Active
- 2019-05-09 JP JP2021513373A patent/JP2021522864A/ja active Pending
- 2019-05-09 CN CN202510720759.5A patent/CN120571006A/zh active Pending
- 2019-05-09 CA CA3099726A patent/CA3099726A1/en active Pending
- 2019-05-09 AU AU2019267680A patent/AU2019267680C1/en active Active
- 2019-05-09 US US17/053,835 patent/US11773141B2/en active Active
- 2019-05-09 ES ES19799463T patent/ES2985391T3/es active Active
- 2019-05-09 PL PL19799463.5T patent/PL3810625T3/pl unknown
- 2019-05-09 KR KR1020257005383A patent/KR20250027279A/ko active Pending
- 2019-05-09 CN CN201980046550.8A patent/CN112513063A/zh active Pending
- 2019-05-09 CN CN202410997275.0A patent/CN119113097A/zh active Pending
- 2019-05-09 WO PCT/US2019/031483 patent/WO2019217654A1/en not_active Ceased
- 2019-05-09 EP EP24166331.9A patent/EP4389222A3/en active Pending
- 2019-05-09 KR KR1020207034973A patent/KR20210010872A/ko not_active Ceased
-
2023
- 2023-08-21 US US18/452,698 patent/US12202862B2/en active Active
-
2024
- 2024-04-17 JP JP2024066590A patent/JP2024105291A/ja active Pending
- 2024-10-18 AU AU2024227453A patent/AU2024227453A1/en active Pending
- 2024-12-10 US US18/975,969 patent/US20250145669A1/en active Pending
- 2024-12-20 US US18/990,652 patent/US20250333450A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3187832B2 (ja) | 抗原発現キメラタンパク質 | |
| WO2022218272A1 (zh) | 新型冠状病毒突变株s蛋白及其亚单位疫苗 | |
| CN104271594B (zh) | 用于初免‑加强疫苗的水疱性口炎病毒 | |
| JP2002532387A (ja) | ペプチドリガンドを介して結合された複数の免疫原性成分を有するｈｂｖコア抗原粒子 | |
| CN101367869B (zh) | 用于预防、诊断及治疗戊型肝炎病毒的多肽,及它们作为诊断试剂和疫苗 | |
| TWI695842B (zh) | 類黃熱病毒粒子 | |
| CN114437185B (zh) | 冠状病毒三聚体亚单位疫苗及其应用 | |
| CN1610697A (zh) | 戊型肝炎病毒单克隆抗体或其结合活性片段及其用途 | |
| JP7403733B2 (ja) | インフルエンザｈａスプリットワクチンの製造方法 | |
| JP2023522154A5 (https=) | ||
| CN105085626A (zh) | 人肠道病毒的广谱亲和表位多肽、抗体及其用途 | |
| KR101581487B1 (ko) | 신규 융합 단백질과 상기 단백질의 ｃ형 간염 백신으로의 사용 | |
| WO2023009028A1 (ru) | Однодоменное антитело и его модификации, специфически связывающиеся с rbd s белка вируса sars-cov-2 | |
| JP2017527293A5 (https=) | ||
| JP2021522864A5 (https=) | ||
| CN100516222C (zh) | 一种针对hbv s-表面抗原的单克隆抗体可变区及编码它的基因 | |
| CN114409803B (zh) | 流感病毒三聚体亚单位疫苗及其应用 | |
| WO2018037246A4 (en) | Immunogenic composition | |
| RU2358981C2 (ru) | Универсальная вакцина против вируса гриппа птиц | |
| CN102464721B (zh) | 针对人肠道病毒71型的重组广谱性疫苗 | |
| CN115850398B (zh) | 新型冠状病毒奥密克戎系列变异株的多肽组合物及其应用 | |
| CN117396493A (zh) | 氨基酸、核苷酸和表达它们的载体及其在预防沙贝病毒感染中的用途 | |
| WO2007104263A1 (zh) | 一种乙型肝炎病毒疫苗增效蛋白及其基因 | |
| CN113185583A (zh) | 一种预防SARS-CoV-2重组蛋白疫苗及其制备方法 | |
| RU2006129097A (ru) | Новые тат-комплексы и включающие их вакцины |